Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-15T09:45:02.484Z Has data issue: false hasContentIssue false
  • English
  • Français

Ataxia and Diplopia in a Patient with Chronic Lymphocytic Leukemia

Published online by Cambridge University Press:  02 December 2014

Teneille E. Gofton ,
David R. Macdonald ,
M. Carmela Tartaglia ,
Donald H. Lee ,
Joseph F. Megyesi  and
Robert R. Hammond
Teneille E. Gofton
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
David R. Macdonald
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Oncology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
M. Carmela Tartaglia
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
Donald H. Lee
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Diagnostic Radiology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
Joseph F. Megyesi
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
Robert R. Hammond
Affiliation:
Departments of Pathology, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada. Clinical Neurological Sciences, London Health Sciences Centre and the University of Western Ontario, London, Ontario, Canada.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical Neuropathological Conference
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 2 , May 2008 , pp. 243 - 246
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Astrom, KE, Mancall, EL, Richardson, EL. Prograssive multifocal leukoencephalopathy; a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin’s Disease. Brain. 1958; 81(1):93–111.Google Scholar
2. Zu Rhein, GM, Chou, SM. Particles resembling papovaviruses in human cerebral demyelinating disease. Science. 1965; 148:1477–9.CrossRefGoogle Scholar
3. Padgett, B, Zu Rhein, GM, Walker, D, Echroade, R, Dessel, B. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971; 1(7712):1257–60.CrossRefGoogle Scholar
4. Knowles, WA, Pipkin, P, Andrews, N, Vyse, A, Minor, P, Brown, DW, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003; 71:115–23.Google Scholar
5. Eash, S, Manley, K, Gasparovic, M, Querbes, W, Atwood, WJ. The human polyomaviruses. Cell Mol Life Sci. 2006; 63:865–76.CrossRefGoogle ScholarPubMed
6. Love, S. Demyelinating diseases. J Clin Path. 2006; 59:1151–9.Google Scholar
7. Koralnik, IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004; 17: 365–70.CrossRefGoogle ScholarPubMed
8. Shankar, SK, Satishchandra, P, Mahadevan, A, Yasha, TC, Nagaraja, D, Taly, AB, et al. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol. 2003; 9 Suppl 1:59–67.CrossRefGoogle Scholar
9. Kiewe, P, Seyfert, S, Korper, S, Rieger, K, Thiel, E, Knauf, W. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma. 2003; 44(10):1815–8.CrossRefGoogle Scholar
10. Shafran, B, Roke, ME, Barr, RM, Cairncross, JG. Contrast enhancing lesions in progressive multifocal leukoencephalopathy: a clinical pathologic correlation. Can J Neurol Sci. 1987; 14(4):600–2.Google Scholar
11. Berger, JR, Houff, S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res. 2006; 28: 299–305.Google Scholar